Evidence map›Paper›PMID 32766819›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Assessing the Potential for Unintended Microbial Consequences of Routine Chlorhexidine Bathing for Prevention of Healthcare-associated Infections.

Ahmed Babiker, Joseph D Lutgring, Scott Fridkin, Mary K Hayden

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Does alternate-day bathing with 2% chlorhexidine improve clinical outcomes in critically ill patients? A systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  5. Article
  6. Variable chlorhexidine MICs acrossAntimicrobial agents and chemotherapy · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ahmed BabikerDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Joseph D LutgringDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Scott FridkinDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Mary K HaydenDepartment of Internal Medicine (Infectious Diseases), Rush University Medical Center, Chicago, Illinois, USA.
Emory University · USCenters for Disease Control and Prevention · USRush University Medical Center · US

Funding

Intramural CDC HHS CC999999NCEZID CDC HHS U54 CK000481NCEZID CDC HHS U54 CK000607
6 · The paper itself

Abstract

Chlorhexidine gluconate (CHG) is an antiseptic that is widely used in healthcare due to its excellent safety profile and wide spectrum of activity. Daily bathing with CHG has proven to be effective in the prevention of healthcare-associated infections and multidrug-resistant pathogen decolonization. Despite the proven benefits of CHG use, there remain concerns and unanswered questions about the potential for unintended microbial consequences of routine CHG bathing. This review aims to explore some of these questions.

Indexed as

Anti-Infective Agents, LocalCross InfectionBathsChlorhexidineDelivery of Health CareHumansAnti-Infective Agents, LocalChlorhexidineantibiotic resistanceantisepticchlorhexidine gluconatedecolonizationhealthcare-associated infections

Identifiers

PMID32766819
PMCPMC8432606
OpenAlexW3047734736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.